7,3',4'-Trimethoxyflavone

7,3',4'-Trimethoxyflavone

SCHEMBL987112

COc1ccc2c(=O)cc(-c3ccc(OC)c(OC)c3)oc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 1.00
CSNK2A2 P19784 3/20 0.79
CSNK2B P67870 3/20 0.79
CSNK2A1 P68400 3/20 0.79
MAOB P27338 4/20 0.76
CYP3A4 P08684 5/20 0.73
KDM4E B2RXH2 4/20 0.73
ALDH1A1 P00352 4/20 0.73
HPGD P15428 4/20 0.73
HSD17B10 Q99714 4/20 0.73
MEN1 O00255 3/20 0.73
KMT2A Q03164 3/20 0.73
SMN1; SMN2 Q16637 3/20 0.73
MAPT P10636 3/20 0.73
MAPK1 P28482 2/20 0.73
THRB P10828 2/20 0.73
GLA P06280 1/20 0.73
USP2 O75604 1/20 0.71
RECQL P46063 1/20 0.71
TP53 P04637 3/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29435863 0.88 CSNK2A2 (0.81) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
SCHEMBL26117897 0.88 CSNK2A2 (0.81) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
4,7-Dimethoxyflavone SCHEMBL3470601 0.87 MAOB (1.00) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
SCHEMBL4400168 0.86 FYN (0.81) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
SCHEMBL6555693 0.86 PABPC1 (0.76) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
3',4'-Dimethoxyflavone SCHEMBL1675954 0.84 CYP3A4 (1.00) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
3',4'-Dimethoxyflavone SCHEMBL29623082 0.84 CYP3A4 (1.00) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
SCHEMBL4399922 0.84 ABCB1 (0.72) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
SCHEMBL12830714 0.84 ABCB1 (0.72) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB
3',4'-Dimethoxyflavone SCHEMBL28140373 0.83 CYP3A4 (0.97) ABCB1CSNK2A2CSNK2BCSNK2A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2494874-B1 Control of flavor characteristics of fruit juice TROPICANA PROD INC (US) 2013-12-11 EP claimed
EP-2494874-A1 Control of flavor characteristics of fruit juice TROPICANA PRODUCTS, INC. (US) 2012-09-05 EP claimed
EP-2186531-A2 Improvement of the efficiency of pharmaceutical active agent-releasing medical products through combination with an inhibitor of the P-glycoprotein transport protein BIOTRONIK VI Patent AG (CH) 2010-05-19 EP claimed
US-20100119581-A1 Medical Products That Release Pharmaceutically Active Substances BIOTRONIK VI PATENT AG (CH) 2010-05-13 US claimed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
EP-2730431-B1 Rubber composition and tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2017-06-28 EP disclosed
US-8980352-B2 Control of flavor characteristics of and indicator of freshness in fruit juice TROPICANA PRODUCTS, INC. (US) 2015-03-17 US disclosed
US-20140135433-A1 TIRE WITH RUBBER CONTAINING FLAVONE THE GOODYEAR TIRE & RUBBER COMPANY (US) 2014-05-15 US disclosed
EP-2730431-A1 Rubber composition and tire with rubber containing flavone The Goodyear Tire & Rubber Company (US) 2014-05-14 EP disclosed
EP-2494874-B1 Control of flavor characteristics of fruit juice TROPICANA PROD INC (US) 2013-12-11 EP disclosed
EP-2217098-B1 CONTROL OF FLAVOR CHARACTERISTICS OF AND INDICATOR OF FRESHNESS IN FRUIT JUICE TROPICANA PROD INC (US) 2013-08-07 EP disclosed
US-20120239140-A1 MEDICAL PRODUCT COMPRISING AN ACTIVE COATING BIOTRONIK AG (CH) 2012-09-20 US disclosed
US-20080287374-A1 BREAST CANCER-RESISTANT PROTEIN INHIBITOR KABUSHIKI KAISHA YAKULT HONSHA (JP) 2008-11-20 US disclosed
EP-1391327-B1 Tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2008-09-03 EP disclosed
US-20060135445-A1 Breast cancer-resistant protein inhibitor KABUSHIKI KAISHA YAKULT HONSHA (JP) 2006-06-22 US disclosed
EP-1591112-A1 BREAST CANCER-RESISTANT PROTEIN INHIBITOR Kabushiki Kaisha Yakult Honsha (JP) 2005-11-02 EP disclosed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US disclosed
EP-1391327-A1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2004-02-25 EP disclosed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 WO disclosed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135445-A1 Breast cancer-resistant protein inhibitor ABCC1, BCR, BRCA1 ABCB1 4/4885CSNK2A2 2298/4885CSNK2B 2245/4885
US-20080287374-A1 BREAST CANCER-RESISTANT PROTEIN INHIBITOR ABCC1, BCR, BRCA1 ABCB1 4/4885CSNK2A2 2298/4885CSNK2B 2245/4885
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP ABCB1 2498/4885CSNK2A2 3078/4885CSNK2B 2902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.